Li Li

Li Li, Ph.D., serves as an Assistant Professor at Texas Tech University School of Pharmacy, where she conducts innovative research at the intersection of analytical chemistry and disease modeling. Her work is affiliated with the Institute for One Health Innovation, reflecting her commitment to interdisciplinary approaches in biomedical research.

Dr. Li's research focuses on combining mass spectrometry-based analytical platforms with cell disease models to explore novel drug targets. Her work specifically investigates connections between metabolic disorders such as diabetes and cancer with neurodegenerative diseases, representing a unique approach to understanding disease mechanisms across traditionally separate medical domains.

Her laboratory utilizes advanced analytical techniques to identify potential therapeutic targets that could address multiple disease conditions simultaneously, potentially leading to more efficient treatment strategies for complex health conditions that often co-occur in patient populations.

Dr. Li maintains active correspondence through her university email address and participates in the broader research initiatives of the Institute for One Health Innovation at Texas Tech University.